Compounding with Biotechnology Products, Part 2: Product-specific Considerations

Area of Science:

• Biotechnology
• Pharmaceutical Sciences
• Pharmacology

Background:

• Biotechnology drugs are produced using living organisms and advanced techniques like recombinant DNA and monoclonal antibodies.
• These pharmaceuticals aid in disease diagnosis, treatment, and prevention but pose risks requiring vigilant safety surveillance.
• Pharmacists are essential in reporting and monitoring adverse events associated with these novel agents.

Purpose of the Study:

• To discuss formulations of commercially available biotechnology products.
• To explain the purpose of various ingredients in these formulations.
• To highlight unique aspects of biotechnology drug formulations.

Main Methods:

• Review of commercially available biotechnology product formulations.
• Analysis of excipient roles in drug stability and safety.
• Discussion of compounding procedures and sterility maintenance.

Main Results:

• Identification of specific formulations for biotechnology drugs.
• Explanation of the function of diverse excipients in drug preparations.
• Emphasis on maintaining biologic activity and sterility during compounding.

Conclusions:

• Pharmacists must understand biotechnology agents and their excipients for safe compounding.
• Simple, sterile procedures are vital for preparing biotechnology drugs.
• Pharmacists are key in educating patients on storage, preparation, and administration.